ARCHIVES

New Drug for Lymphoma Enters Phase II Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

The Tivozanib Timeline

May 10, 2013

May issue of Business & Regulatory Report, 8 additional pages, included.

May 28, 2004

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999

FDA developing guidelines for oncology endpoints.

May 7, 2004

NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants

November 30, 1990